The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Role of Magnetic Resonance Imaging in the Management of Patients With Multiple Myeloma: A Consensus Statement
Open accessAbstract
Purpose: The aim of International Myeloma Working Group was to develop practical recommendations for the use of magnetic resonance imaging (MRI) in multiple myeloma (MM). Methods: An interdisciplinary panel of clinical experts on MM and myeloma bone disease developed recommendations for the value of MRI based on data published through March 2014. Recommendations: MRI has high sensitivity for the early detection of marrow infiltration by myeloma cells compared with other radiographic methods. Thus, MRI detects bone involvement in patients with myeloma much earlier than the myeloma-related bone destruction, with no radiation exposure. It is the gold standard for the imaging of axial skeleton, for the evaluation of painful lesions, and for distinguishing benign versus malignant osteoporotic vertebral fractures. MRI has the ability to detect spinal cord or nerve compression and presence of soft tissue masses, and it is recommended for the workup of solitary bone plasmacytoma. Regarding smoldering or asymptomatic myeloma, all patients should undergo whole-body MRI (WB-MRI; or spine and pelvic MRI if WB-MRI is not available), and if they have > one focal lesion of a diameter > 5 mm, they should be considered to have symptomatic disease that requires therapy. In cases of equivocal small lesions, a second MRI should be performed after 3 to 6 months, and if there is progression on MRI, the patient should be treated as having symptomatic myeloma. MRI at diagnosis of symptomatic patients and after treatment (mainly after autologous stem-cell transplantation) provides prognostic information; however, to date, this does not change treatment selection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The International Myeloma Working Group (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04355.x · Cited by 2,321
Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma
Mateos, M.-V., Hernández, M.-T., Giraldo, P., de la Rubia, J., de Arriba, F., Corral, L. L., Rosiñol, L., Paiva, B., Palomera, L., Bargay, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300439 · Cited by 1,171 · cited 1×
“03).(61) An important issue is whether patients who have two small focal lesions ( 5 mm) should be considered as having symptomatic myeloma and how to manage them.”
BackgroundSelf-citationRole of Cardiac Magnetic Resonance Imaging in the Detection of Cardiac Amyloidosis
Syed, I. S., Glockner, J. F., Feng, D., Araoz, P. A., Martinez, M. W., Edwards, W. D., Gertz, M. A., Dispenzieri, A., Oh, J. K., Bellavia, D., et al. (2010) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2009.09.023 · Cited by 545
Bartel, T. B., Haessler, J., Brown, T. L. Y., Shaughnessy, J. D., van Rhee, F., Anaissie, E., Alpe, T., Angtuaco, E., Walker, R., Epstein, J., et al. (2009) · Blood · doi:10.1182/blood-2009-03-213280 · Cited by 518
Self-citationVarettoni, M., Corso, A., Pica, G., Mangiacavalli, S., Pascutto, C., & Lazzarino, M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp329 · Cited by 487
Dimopoulos, M., Terpos, E., Comenzo, R. L., Tosi, P., Beksac, M., Sezer, O., Siegel, D., Lokhorst, H., Kumar, S., Rajkumar, S. V., et al. (2009) · Leukemia · doi:10.1038/leu.2009.89 · Cited by 482
Self-citationBaur, A., Stäbler, A., Brüning, R., Bartl, R., Krödel, A., Reiser, M., & Deimling, M. (1998) · Radiology · doi:10.1148/radiology.207.2.9577479 · Cited by 440
Magnetic Resonance Imaging in Multiple Myeloma: Diagnostic and Clinical Implications
Walker, R., Barlogie, B., Haessler, J., Tricot, G., Anaissie, E., Shaughnessy, J. D., Epstein, J., van Hemert, R., Erdem, E., Hoering, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.5803 · Cited by 417
Self-citationSolitary plasmacytoma of bone and asymptomatic multiple myeloma
Dimopoulos, M. A., Moulopoulos, L. A., Maniatis, A., & Alexanian, R. (2000) · Blood · doi:10.1182/blood.v96.6.2037 · Cited by 397
Self-citationHillengass, J., Fechtner, K., Weber, M.-A., Bäuerle, T., Ayyaz, S., Heiss, C., Hielscher, T., Moehler, T. M., Egerer, G., Neben, K., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.5356 · Cited by 381
Self-citationZamagni, E., Nanni, C., Patriarca, F., Englaro, E., Castellucci, P., Geatti, O., Tosi, P., Tacchetti, P., Cangini, D., Perrone, G., et al. (2007) · Haematologica · doi:10.3324/haematol.10554 · Cited by 354
Self-citationDurie, B. G. M. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.11.037 · Cited by 300
Self-citationToward an optimal distribution of b values for intravoxel incoherent motion imaging
Lemke, A., Stieltjes, B., Schad, L. R., & Laun, F. B. (2011) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2011.03.004 · Cited by 286
Magnetic resonance imaging in the staging of solitary plasmacytoma of bone.
Moulopoulos, L. A., Dimopoulos, M. A., Weber, D., Fuller, L., Libshitz, H. I., & Alexanian, R. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.7.1311 · Cited by 223
Self-citationRegelink, J. C., Minnema, M. C., Terpos, E., Kamphuis, M. H., Raijmakers, P. G., Pieters – van den Bos, I. C., Heggelman, B. G. F., Nievelstein, R., Otten, R. H. J., van Lammeren – Venema, D., et al. (2013) · British Journal of Haematology · doi:10.1111/bjh.12346 · Cited by 211
Self-citationWhole-Body Diffusion-weighted MR Imaging for Assessment of Treatment Response in Myeloma
Giles, S. L., Messiou, C., Collins, D. J., Morgan, V. A., Simpkin, C. J., West, S., Davies, F. E., Morgan, G. J., & deSouza, N. M. (2014) · Radiology · doi:10.1148/radiol.13131529 · Cited by 203
Self-citationMagnetic Resonance Imaging of the Bone Marrow in Hematologic Malignancies
Moulopoulos, L. A., & Dimopoulos, M. A. (1997) · Blood · doi:10.1182/blood.v90.6.2127 · Cited by 202
Self-citationUsmani, S. Z., Mitchell, A., Waheed, S., Crowley, J., Hoering, A., Petty, N., Brown, T., Bartel, T., Anaissie, E., van Rhee, F., et al. (2013) · Blood · doi:10.1182/blood-2012-08-451690 · Cited by 201
Self-citationDhodapkar, M. V., Sexton, R., Waheed, S., Usmani, S., Papanikolaou, X., Nair, B., Petty, N., Shaughnessy, J. D., Hoering, A., Crowley, J., et al. (2014) · Blood · doi:10.1182/blood-2013-07-515239 · Cited by 192 · cited 1×
“A prospective study involving 331 patients with MGUS or SMM revealed that the detection of multiple ( one) focal lesions by MRI conferred an increased risk of progression.(66) In another large study, which included only patients with MGUS (n 137) who underwent WB-MRI at diagnosis, a focal infiltration pattern was dete…”
BackgroundSelf-citationMoulopoulos, L. A., Dimopoulos, M. A., Smith, T. L., Weber, D. M., Delasalle, K. B., Libshitz, H. I., & Alexanian, R. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.1.251 · Cited by 185
Self-citationvan de Donk, N. W. C. J., Palumbo, A., Johnsen, H. E., Engelhardt, M., Gay, F., Gregersen, H., Hajek, R., Kleber, M., Ludwig, H., Morgan, G., et al. (2014) · Haematologica · doi:10.3324/haematol.2013.100552 · Cited by 176
Self-citationKastritis, E., Terpos, E., Moulopoulos, L. A., Spyropoulou‐Vlachou, M., Kanellias, N., Eleftherakis-Papaiakovou, E., Gkotzamanidou, M. A., Migkou, M., Gavriatopoulou, M., Ρούσσου, Μ., et al. (2012) · Leukemia · doi:10.1038/leu.2012.309 · Cited by 174
Self-citationSkeletal survey in advanced multiple myeloma: radiographic versus MR imaging survey
Lecouvet, F. E., Malghem, J., Michaux, L., Maldague, B., Ferrant, A., Michaux, J., & Vande Berg, B. C. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01529.x · Cited by 159
Risk of disease progression in asymptomatic multiple myeloma
Dimopoulos, M. A., Moulopoulos, A., Smith, T., Delasalle, K. B., & Alexanian, R. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90120-e · Cited by 158
Self-citationDiffusion MR Imaging for Monitoring of Treatment Response
Padhani, A. R., & Koh, D. (2010) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2010.10.004 · Cited by 141
Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging.
Lecouvet, F. E., Berg, B. C. V., Michaux, L., Malghem, J. J., Maldague, B., Jamart, J., Ferrant, A., & Michaux, J. (1998) · Radiology · doi:10.1148/radiology.209.3.9844655 · Cited by 138
Hillengaß, J., Ayyaz, S., Kilk, K., Weber, M., Hielscher, T., Shah, R., Hose, D., Delorme, S., Goldschmidt, H., & Neben, K. (2012) · Haematologica · doi:10.3324/haematol.2012.065359 · Cited by 128
Self-citationBäuerle, T., Hillengaß, J., Fechtner, K., Zechmann, C. M., Grenacher, L., Moehler, T. M., Heiß, C., Barbara, W.-G., Neben, K., Kauczor, H., et al. (2009) · Radiology · doi:10.1148/radiol.2522081756 · Cited by 127
Self-citationMerz, M., Hielscher, T., Wagner, B., Sauer, S., Shah, S., Raab, M., Jauch, A. T., Neben, K., Hose, D., Egerer, G., et al. (2014) · Leukemia · doi:10.1038/leu.2014.75 · Cited by 125
Self-citationMoulopoulos, L. A., Gika, D., Anagnostopoulos, Α., Delasalle, K. B., Weber, D. M., Alexanian, R., & Dimopoulos, M. A. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi362 · Cited by 121
Self-citationHillengaß, J., & Landgren, O. (2013) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2012.740559 · Cited by 111
Spinnato, P., Bazzocchi, A., Brioli, A., Nanni, C., Zamagni, E., Albisinni, U., Cavo, M., Fanti, S., Battista, G., & Salizzoni, E. (2012) · European Journal of Radiology · doi:10.1016/j.ejrad.2012.06.028 · Cited by 104
Self-citationDerlin, T., Peldschus, K., Münster, S., Bannas, P., Herrmann, J., Stübig, T., Habermann, C. R., Adam, G., Kröger, N. M., & Weber, C. (2012) · European Radiology · doi:10.1007/s00330-012-2600-5 · Cited by 98
Waheed, S., Mitchell, A., Usmani, S. Z., Epstein, J., Yaccoby, S., Nair, B. P., Hemert, R. L. V., Angtuaco, E. J., Brown, T., Bartel, T. B., et al. (2012) · Haematologica · doi:10.3324/haematol.2012.066555 · Cited by 81
Self-citationWhole body MRI: Improved lesion detection and characterization with diffusion weighted techniques
Attariwala, R., & Picker, W. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24285 · Cited by 78
Pepe, J., Petrucci, M. T., Nofroni, I., Fassino, V., Diacinti, D., Romagnoli, E., & Minisola, S. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06217.x · Cited by 77
Hillengaß, J., Weber, M., Kilk, K., Listl, K., Wagner, B., Hillengaß, M., Hielscher, T., Farid, A., Neben, K., Delorme, S., et al. (2013) · Leukemia · doi:10.1038/leu.2013.244 · Cited by 68
Self-citationBannas, P., Hentschel, H., Bley, T. A., Treszl, A., zu Eulenburg, C., Derlin, T., Yamamura, J., Adam, G., Stübig, T., Kröger, N. M., et al. (2012) · European Radiology · doi:10.1007/s00330-012-2445-y · Cited by 63
Narquin, S., Ingrand, P., Azaïs, I., Delwail, V., Vialle, R., Boucecbi, S., & Tasu, J. P. (2013) · Diagnostic and Interventional Imaging · doi:10.1016/j.diii.2013.01.005 · Cited by 34
Clinical and research applications of simultaneous positron emission tomography and MRI
Fraioli, F., & Punwani, S. (2013) · British Journal of Radiology · doi:10.1259/bjr.20130464 · Cited by 33
Song, M., Chung, J. S., Lee, J., Min, C., Ahn, J., Lee, S., Shin, D., Bae, S., Hong, J., Lee, G., et al. (2014) · British Journal of Haematology · doi:10.1111/bjh.12820 · Cited by 31
Echo Planar Imaging of the Abdomen
ller, M. F. M., & Edelman, R. R. (1995) · Topics in Magnetic Resonance Imaging · doi:10.1097/00002142-199500720-00007 · Cited by 21
Khalafallah, A. A., Snarski, A., Heng, R. C., HUGHES, R. V., Renu, S., Arm, J., Dutchke, R., Robertson, I. K., & To, L. B. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-002025 · Cited by 12
Durie, B. G. M., & Salmon, S. E. (1975) · Cancer · doi:10.1002/1097-0142(197509)36:3<842::aid-cncr2820360303>3.0.co;2-u
Self-citation
Cited by
Kumar, S., Paiva, B., Anderson, K. C., Durie, B., Landgren, O., Moreau, P., Munshi, N., Lonial, S., Bladé, J., Mateos, M.-V., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30206-6 · Cited by 3,061
Self-citationMultiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
Dimopoulos, M. A., Moreau, P., Terpos, E., Mateos, M. V., Zweegman, S., Cook, G., Delforge, M., Hájek, R., Schjesvold, F., Cavo, M., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2020.11.014 · Cited by 900
Self-citationCavo, M., Terpos, E., Nanni, C., Moreau, P., Lentzsch, S., Zweegman, S., Hillengass, J., Engelhardt, M., Usmani, S. Z., Vesole, D. H., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30189-4 · Cited by 544
Self-citationUpdated Diagnostic Criteria and Staging System for Multiple Myeloma
Rajkumar, S. V. (2016) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_159009 · Cited by 350
Self-citationCaers, J., Paiva, B., Zamagni, E., Leleu, X., Bladé, J., Kristinsson, S. Y., Touzeau, C., Abildgaard, N., Terpos, E., Heusschen, R., et al. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0549-1 · Cited by 336
Self-citation
Metadata
- Authors
- Dimopoulos, M. A., Hillengass, J., Usmani, S., Zamagni, E., Lentzsch, S., Davies, F. E., Raje, N., Sezer, O., Zweegman, S., Shah, J., Badros, A., Shimizu, K., Moreau, P., Chim, C.-S., Lahuerta, J. J., Hou, J., Jurczyszyn, A., Goldschmidt, H., Sonneveld, P., Palumbo, A., Ludwig, H., Cavo, M., Barlogie, B., Anderson, K., Roodman, G. D., Rajkumar, S. V., Durie, B. G. M., & Terpos, E.
- Venue
- Journal of Clinical Oncology
- Published
- 2015-02-20
- Volume
- 33
- Issue
- 6
- Pages
- 657-664
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2096672426
- Cited by
- 393
- References
- 44
- FWCI
- 33.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.